CRISIL has, after due consideration, reaffirmed its "CRISIL Al+" (pronounced as CRISIL A one plus rating) rating on the Rs.1300 Crore Commercial Paper (Enhanced from Rs.250 Crore), of Cadila Healthcare Limited. Instruments with this rating are considered to have very strong degree of safety regarding timely payment of financial obligations. Such instruments carry lowest credit risk.
Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.394.6 as compared to the previous close of Rs. 409.15. The total number of shares traded during the day was 213198 in over 4291 trades.
The stock hit an intraday high of Rs. 416.95 and intraday low of 390.5. The net turnover during the day was Rs. 86599776.